These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29517285)

  • 1. Multidrug-resistant Neisseria gonorrhoeae: future therapeutic options.
    Kahler CM
    Future Microbiol; 2018 Apr; 13():499-501. PubMed ID: 29517285
    [No Abstract]   [Full Text] [Related]  

  • 2. Could vaccination against Neisseria gonorrhoeae be on the horizon?
    Russell MW
    Future Microbiol; 2018 Apr; 13():495-497. PubMed ID: 29517283
    [No Abstract]   [Full Text] [Related]  

  • 3. Neisseria: recent advances and future challenges.
    Criss AK; Tang C
    Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 28957453
    [No Abstract]   [Full Text] [Related]  

  • 4. Neisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development.
    Rice PA; Shafer WM; Ram S; Jerse AE
    Annu Rev Microbiol; 2017 Sep; 71():665-686. PubMed ID: 28886683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting.
    Cristillo AD; Bristow CC; Torrone E; Dillon JA; Kirkcaldy RD; Dong H; Grad YH; Nicholas RA; Rice PA; Lawrence K; Oldach D; Shafer WM; Zhou P; Wi TE; Morris SR; Klausner JD
    Sex Transm Dis; 2019 Mar; 46(3):e18-e25. PubMed ID: 30363025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypes and antimicrobial-resistant phenotypes of Neisseria gonorrhoeae in Portugal (2004-2009).
    Florindo C; Pereira R; Boura M; Nunes B; Paulino A; Gomes JP; Borrego MJ
    Sex Transm Infect; 2010 Nov; 86(6):449-53. PubMed ID: 20940158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of mutations in quinolone-resistance-determining regions and mtrR loci in polyclonal Neisseria gonorrhoeae isolates at a tertiary hospital in Southern Taiwan.
    Chen PL; Lee HC; Yan JJ; Hsieh YH; Lee NY; Ko NY; Lin CW; Chang CM; Wu CJ; Lee CC; Ko WC
    J Formos Med Assoc; 2010 Feb; 109(2):120-7. PubMed ID: 20206836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The monitoring of Neisseria gonorrhoeae infection incidence and its resistance in Suceava County].
    Filipiuc S; Nicolae O; Luncă C; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1238-42. PubMed ID: 20191906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delaying the widespread emergence of cephalosporin-resistant gonorrhoea: what is the best target?
    Tuddenham S; Ghanem KG
    Sex Transm Infect; 2015 Jun; 91(4):232-3. PubMed ID: 25990778
    [No Abstract]   [Full Text] [Related]  

  • 10. Global resistance of Neisseria gonorrhoeae: when theory becomes reality.
    Lewis DA
    Curr Opin Infect Dis; 2014 Feb; 27(1):62-7. PubMed ID: 24275696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging resistance in Neisseria meningitidis and Neisseria gonorrhoeae.
    Stefanelli P
    Expert Rev Anti Infect Ther; 2011 Feb; 9(2):237-44. PubMed ID: 21342071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda.
    Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D
    J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug Resistance in Neisseria gonorrhoeae: Identification of Functionally Important Residues in the MtrD Efflux Protein.
    Chitsaz M; Booth L; Blyth MT; O'Mara ML; Brown MH
    mBio; 2019 Nov; 10(6):. PubMed ID: 31744915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects of untreatable gonorrhea and ways forward.
    Whiley DM; Lahra MM; Unemo M
    Future Microbiol; 2015; 10(3):313-6. PubMed ID: 25812453
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae.
    Densen P
    Clin Microbiol Rev; 1989 Apr; 2 Suppl(Suppl):S11-7. PubMed ID: 2497954
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial susceptibility and genotypic distribution of Neisseria gonorrhoeae: a 2-year study in Tunisia.
    Ferjani A; Marzouk M; Saghrouni F; Hadj Ali M; Boukadida J
    Med Mal Infect; 2013 May; 43(5):211-2. PubMed ID: 23623306
    [No Abstract]   [Full Text] [Related]  

  • 17. Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?
    Rice LB
    Sex Transm Infect; 2015 Jun; 91(4):238-40. PubMed ID: 25926405
    [No Abstract]   [Full Text] [Related]  

  • 18. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health.
    Ndowa F; Lusti-Narasimhan M; Unemo M
    Sex Transm Infect; 2012 Aug; 88(5):317-8. PubMed ID: 22798629
    [No Abstract]   [Full Text] [Related]  

  • 19. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae.
    Tapsall JW; Ndowa F; Lewis DA; Unemo M
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):821-34. PubMed ID: 19735224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility profile of
    Affolabi D; Goma E; Sogbo F; Ahotin G; Orekan J; Massou F; Behanzin L; Guédou F; Alary M
    Sex Transm Infect; 2018 Feb; 94(1):20. PubMed ID: 29021407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.